AngioDynamics Inc
ANGO13.100USD
-0.060-0.46%
終値 12/26, 16:00（ET）15分遅れの株価
542.95M時価総額
損失額直近12ヶ月PER
詳細情報 AngioDynamics Inc 企業名
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
AngioDynamics Incの企業情報
企業コードANGO
会社名AngioDynamics Inc
上場日May 27, 2004
最高経営責任者「CEO」Clemmer (James C)
従業員数675
証券種類Ordinary Share
決算期末May 27
本社所在地14 Plaza Drive
都市LATHAM
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号12110
電話番号15187981215
ウェブサイトhttps://www.angiodynamics.com/
企業コードANGO
上場日May 27, 2004
最高経営責任者「CEO」Clemmer (James C)
AngioDynamics Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-26.11%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Ms. Lorinda A. Burgess
Ms. Lorinda A. Burgess
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-26.11%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
66.46M
87.78%
International
9.26M
12.22%
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
Divisadero Street Capital Management, LP
8.93%
BlackRock Institutional Trust Company, N.A.
7.05%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.74%
他の
65.84%
株主統計
株主統計
比率
Divisadero Street Capital Management, LP
8.93%
BlackRock Institutional Trust Company, N.A.
7.05%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.74%
他の
65.84%
種類
株主統計
比率
Investment Advisor
36.53%
Investment Advisor/Hedge Fund
35.68%
Hedge Fund
21.31%
Individual Investor
6.44%
Research Firm
1.99%
Pension Fund
1.68%
Bank and Trust
0.25%
Venture Capital
0.06%
Insurance Company
0.03%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
311
40.19M
106.71%
-10.46K
2025Q3
344
40.20M
109.06%
+1.51M
2025Q2
370
37.97M
110.38%
+1.85M
2025Q1
372
36.50M
106.59%
-6.63M
2024Q4
361
34.34M
98.76%
+1.35M
2024Q3
371
33.44M
109.60%
-216.03K
2024Q2
370
33.66M
118.59%
-3.23M
2024Q1
368
36.03M
115.74%
-10.10M
2023Q4
378
37.01M
114.23%
+355.36K
2023Q3
364
36.64M
109.90%
-219.51K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Divisadero Street Capital Management, LP
3.40M
8.24%
+2.44M
+253.67%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.96M
7.2%
-94.58K
-3.09%
Jun 30, 2025
Systematic Financial Management, L.P.
2.51M
6.09%
+12.62K
+0.51%
Jun 30, 2025
Point72 Asset Management, L.P.
1.95M
4.73%
+1.02M
+109.86%
Jun 30, 2025
The Vanguard Group, Inc.
2.49M
6.04%
-3.33K
-0.13%
Jun 30, 2025
Millennium Management LLC
2.15M
5.21%
+746.42K
+53.34%
Jul 16, 2025
Armistice Capital LLC
1.53M
3.71%
-566.18K
-27.04%
Jun 30, 2025
Segall Bryant & Hamill, LLC
1.36M
3.29%
-27.75K
-2.00%
Jun 30, 2025
Bastion Asset Management Inc.
959.04K
2.33%
+304.22K
+46.46%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.17M
2.85%
+7.01K
+0.60%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Health Care Equipment ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.63%
Vanguard US Multifactor ETF
0.15%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.06%
Avantis US Small Cap Equity ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
iShares Russell 2000 Value ETF
0.02%
詳細を見る
State Street SPDR S&P Health Care Equipment ETF
比率0.79%
Invesco NASDAQ Future Gen 200 ETF
比率0.63%
Vanguard US Multifactor ETF
比率0.15%
iShares Micro-Cap ETF
比率0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0.07%
Fidelity Enhanced Small Cap ETF
比率0.06%
Avantis US Small Cap Equity ETF
比率0.06%
Invesco RAFI US 1500 Small-Mid ETF
比率0.04%
iShares Russell 2000 Value ETF
比率0.02%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
AngioDynamics Incの上位5名の株主は誰ですか？
AngioDynamics Incの上位5名の株主は以下のとおりです。
Divisadero Street Capital Management, LPは3.40M株を保有しており、これは全体の8.24%に相当します。
BlackRock Institutional Trust Company, N.A.は2.96M株を保有しており、これは全体の7.20%に相当します。
Systematic Financial Management, L.P.は2.51M株を保有しており、これは全体の6.09%に相当します。
Point72 Asset Management, L.P.は1.95M株を保有しており、これは全体の4.73%に相当します。
The Vanguard Group, Inc.は2.49M株を保有しており、これは全体の6.04%に相当します。
Divisadero Street Capital Management, LPは3.40M株を保有しており、これは全体の8.24%に相当します。
BlackRock Institutional Trust Company, N.A.は2.96M株を保有しており、これは全体の7.20%に相当します。
Systematic Financial Management, L.P.は2.51M株を保有しており、これは全体の6.09%に相当します。
Point72 Asset Management, L.P.は1.95M株を保有しており、これは全体の4.73%に相当します。
The Vanguard Group, Inc.は2.49M株を保有しており、これは全体の6.04%に相当します。
AngioDynamics Incの株主タイプ上位3種は何ですか？
AngioDynamics Incの株主タイプ上位3種は、
Divisadero Street Capital Management, LP
BlackRock Institutional Trust Company, N.A.
Systematic Financial Management, L.P.
Divisadero Street Capital Management, LP
BlackRock Institutional Trust Company, N.A.
Systematic Financial Management, L.P.
AngioDynamics Inc（ANGO）の株式を保有している機関の数はいくつですか？
2025Q4時点で、AngioDynamics Incの株式を保有している機関は311社あり、保有株式の総市場価値は約40.19Mで、全体の106.71%を占めています。2025Q3と比較して、機関の持ち株は-2.34%増加しています。
AngioDynamics Incの最大の収益源は何ですか？
FY2026Q1において、--部門がAngioDynamics Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
